HealthCare Global Enterprises Ltd
P&L
Quarterly Consolidated
vs Q2 FY26
HealthCare Global Enterprises Ltd. Reports 13% YoY Revenue Growth in Q3FY26
06 Feb 2026 · 6 Feb, 10:52 pm
Summary
HealthCare Global Enterprises Ltd. (HCG), India’s largest dedicated cancer hospital network, under the brand “HCG”, announced its financial results for the quarter and nine months ended 31% December 2025.
Key Highlights
- 1
Revenue from Operations for Q3FY26 is 6,331 Rs. Mn.
- 2
Revenue from Operations for Q3FY25 is 5,586 Rs. Mn.
- 3
Revenue from Operations for 9M FY26 is 18,931 Rs. Mn.
- 4
Revenue from Operations for 9M FY25 is 16,377 Rs. Mn.
- 5
Adjusted EBITDA for Q3FY26 is 1,108 Rs. Mn.
- 6
Adjusted EBITDA for Q3FY25 is 923 Rs. Mn.
- 7
Adjusted EBITDA for 9M FY26 is 3,458 Rs. Mn.
- 8
Adjusted EBITDA for 9M FY25 is 2,893 Rs. Mn.
- 9
HCG is expanding across India and focusing on translating innovation into measurable outcomes.
Management Comments
Dr. B. S. Ajaikumar
Founder and Non- Executive Chairman, HealthCare Global Enterprises Ltd.
At HCG, our guiding principle is to deliver the right treatment, the first time, with a clear and consistent focus on patient outcomes... This research-led approach, combined with the adoption of proven next-generation technologies, positions HCG at the forefront of cancer care.
Dr. Manish Mattoo
CEO HealthCare Global Enterprises Ltd.
Our Q3 performance reflects steady execution across the network... The quarter further demonstrated the scalability of our model... HCG’s focused single-specialty model, anchored in integrated care delivery, tumour-board-led clinical decision-making, and consistent clinical outcomes, continues to differentiate us in a competitive environment... Alongside this, we have strengthened our leadership bandwidth to support the next phase of growth.
Informational and educational content only. Not investment advice.